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Background: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. The prevalence of IBS in Asian
countries varies from 2.9% to 15.6%. IBS does not result in increased mortality, but is associated with psychological
distress and disruption of work and sleep. Consequently, the evaluation of health-related quality of life (HRQoL) is
an important outcome measure for patients with IBS since it provides a holistic assessment of the patient's
emotional, social and physical function. However, some HRQoL tools can be time-consuming to apply. EQ-5D is a
brief HRQoL tool which has been validated in the Western IBS population but has thus far not been used in Asia.
This study was conducted to determine whether persons with self-reported symptoms that met the Rome III
criteria for IBS had a poorer quality of life than those without these symptoms. We also aimed to determine which
specific aspects of quality of life were most affected and whether any risk factors distinguished those with and
without IBS.
Methods: Self-administered questionnaires which included the Rome III diagnostic questionnaire modules for IBS
and the EQ-5D questionnaire were obtained from participants of a health symposium in Singapore on 31th
October 2010. IBS was diagnosed based on the Rome III Criteria. The main outcome measure was the EQ-5D index
score. The relationship between the presence of IBS and the EQ-5D index score, individual dimensions of EQ-5D
and demographic risk factors were examined.
Results: 449 completed questionnaires were analyzed. The mean EQ-5D index score for IBS was 0.739 which was a
significant reduction compared to non-IBS participants [−0.11 (95% CI: -0.15 to −0.07), p < 0.001]. Multivariate analysis
showed that IBS was significantly associated with younger age and higher education level. Of the five EQ-5D
dimensions, IBS sufferers were significantly affected in mobility, anxiety or depression, usual activity and pain. There was
a "dose related" increase in likelihood of having IBS with increased severity of pain and anxiety or depression.
Conclusion: IBS sufferers have significantly poorer quality of life. Assessment of HRQoL in IBS using the EQ-5D should
be considered in further studies and routine clinical practice.
Background 2.9% to 15.6% [1]. While IBS does not result in increased
Irritable bowel syndrome (IBS), a well-known functional
gastrointestinal disorder, is characterized by abdominal
pain, bloating or abdominal discomfort occurring in as-
sociation with disturbed bowel patterns in the absence
of organic causes detectable by routine investigations
[1]. The prevalence of IBS in Asian countries varies from* Correspondence: wangyutien@gmail.com
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reproduction in any medium, provided the ormortality, it is associated with psychological distress and
disruption of work and sleep.
Consequently, the evaluation of health-related quality of
life (HRQoL) is an important outcome measure for
patients with IBS since it provides a holistic assessment of
the patient’s emotional, social and physical functions [2].
HRQoL is important in assessing both severity and treat-
ment outcomes of IBS [2]. A generic evaluation of HRQoL
also allows for comparisons between diverse diseases and
may aid in decisions about healthcare resource allocation.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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able impact of diabetes and IBS on physical function, and
by evidence of lower mental HRQoL in IBS than in those
with chronic renal failure [3]. The American College of
Gastroenterology recommends the routine screening of
HRQOL in IBS patients [4] in order to holistically assess
the severity and impact of the disease.
The assessment of HRQoL in IBS patients can be quite
time-consuming. The Short Form 36-Item Health Sur-
vey (SF-36), a commonly used HRQoL assessment tool,
may require 7–10 minutes [5], which precludes its use
in routine care. Recently, a brief HRQoL tool, the EQ-
5D [6], was validated in IBS on several Western samples
[7]. The EQ-5D had moderate to strong associations
with SF-36 in the study. While the EQ-5D has been vali-
dated across the 3 major ethnic groups in Singapore
in non IBS studies [8,9], we know of no publication
on its use in IBS in Asia. The EQ-5D comprises of
five questions (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression). Each question con-
sists of responses at 3 levels: no problems, some pro-
blems and extreme problems. There is also a separate
visual analogue scale which is rated from 0 to 100.
This study was conducted to determine whether firstly,
persons from a community sample of opportunity with
self-reported symptoms that met the Rome III criteria
for IBS [10] had a poorer quality of life than those with-
out these symptoms. Secondly, we also aimed to deter-
mine which specific aspects of quality of life were most
affected and thirdly, whether any risk factors distin-
guished those with and without IBS.
Methods
This cross-sectional study consisted of obtaining the self-
reported EQ-5D [11], from all participants attending the
National Foundation for Digestive Diseases Symposium
held at the Raffles City Convention Centre, Singapore on
31th October 2010 (estimated audience size= 850 people).
This free public education symposium discussed gastro-
intestinal malignancies in both English and Mandarin.
The symposium was advertised in Chinese and English
newspapers.
The questionnaire was obtained throughout the dur-
ation of the symposium on the same day by the use of
distribution and collection booths. Study investigators,
who were doctors familiar with IBS and the EQ-5D,
were available to answer questions and assist respon-
dents (if needed ) in the completion of the questionnaire
(provided in English and Chinese).
This study was approved by the Singhealth Centralised
Institutional Review Board. The purpose of the study
was detailed in the cover page of the questionnaire and
consent was inferred from completion and return of
questionnaires.Questionnaires
The questionnnaires included the Rome III diagnostic
questionnaire modules for IBS [10] and the EQ-5D [11]
either in English or Chinese. The questionnaire also
included the participants’ age, gender, ethnic group, edu-
cation level, employment status, presence of other sig-
nificant illnesses and presence of significant illnesses in
another family member of the participant.
IBS was ascribed based on the Rome III diagnostic cri-
teria for IBS [10] which requires abdominal pain or dis-
comfort in at least 3 of the previous 6 months, with 2 or
more of the following criteria: [1] pain or discomfort
improved after defecation; [2] pain or discomfort asso-
ciated with a change in frequency of stool, or [3] pain or
discomfort associated with a change in the form of stool.
HRQoL was assessed using the EQ-5D-3 L [11] which
includes 2 pages of the EQ-5D descriptive system. The
EQ-5D descriptive system comprises the following 5
dimensions; mobility (ability to walk), self-care (ability to
wash and dress oneself ), usual activities (ability to per-
form usual activities such as work, study, housework
and family or leisure activities), pain/discomfort (experi-
encing pain or discomfort) and anxiety/depression (feel-
ing anxious or depressed). Each dimension has 3 levels
of responses: no problems (assigned a rating of 1), some
problems (assigned a rating of 2), or severe problems
(assigned a rating of 3). The respondent indicated his or
her current health state by choosing the most appropri-
ate statement in each dimension. Ratings for each di-
mension were then combined into a 5-digit number that
describes the respondent’s health state. This 5 digit EQ-
5D health state was converted into a single summary
index score by inputing the 5 digit number into the EQ-
5D index calculator available from the EuroQol Group
[12]. In our study, the United Kingdom Value set [13]
was applied as no local value set was available and be-
cause the United Kingdom value set has robust evidence.
The Index score was our primary end-point (range from
−0.6 to 1). A score of 1 represents a health state of full
health and 0 represents a health state of death. A nega-
tive score represents a health state worse than death.
The relationship between demographic risk factors
and the presence of IBS was studied using the binary lo-
gistic regression model. From the significant variables
identified in the univariate analysis, we used the back-
ward stepwise method to identify variables that were in-
dependently and significantly associated with the
outcome using the likelihood ratio test. The odds ratios
and their corresponding 95% confidence intervals were
presented as effect size. We also repeated this modeling
strategy for the various sub-domains within the EQ-5D.
In addition, we used the ordinary least-squares regres-
sion model to analyse factors that were associated with
the overall EQ-5D score. Once again, a backward
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model. Tests for the appropriate assumptions for the
models were carried out. Data was analysed using Stata
V11.2 (Stata Corp, College Station, Tx, USA) and the
level of significance was set at 5%.
Results
464 questionnaires were collected. Of these, a total of
449 questionnaires constituted the analyzable sample. 15
questionnaires were excluded due to incomplete
responses which precluded determination of their IBS
status or EQ-5D index score.
We found that 198/449 (44.1%) of respondents had met
the Rome III diagnostic criteria for IBS. More males had IBS
(53% vs 42%, p=0.015) but the races were equally distribu-
ted among the two groups. There was no association with
having illnesses themselves or in other family members. The
factors associated with IBS were younger age [adjusted OR=
0.98 (95% CI: 0.96 to 0.99)] and a higher education level,
defined as the possession of a diploma, degree or post gradu-
ate qualification [adjusted OR=1.7 (95% CI: 1.11 - 2.58),
p=0.014]. The odds for having IBS were 3.78 times greater
for a person who had done post-graduate studies versus a
person with a primary level education (p=0.014). The odds
for having IBS were also 1.68 times greater for a person who
was employed as compared to one who was unemployed,
retired, a housewife or a student (p=0.009) (Table 1).
IBS was significantly associated with four of the five EQ-
5D dimensions (except “self-care”; p = 0.77). The probabil-
ity of having some mobility problems for persons suffering
from IBS is 2.38 times higher than the probability for the
ones without IBS (p=0.02). The probability of having
some problems with "usual activity" for persons suffering
from IBS is 3.63 times higher than the probability for the
ones without IBS (p < 0.001). In the “pain/discomfort” di-
mension, the probability of having some pain or discom-
fort was 4.92 times higher for persons with IBS versus one
without(p< 0.001) while it was 7.93 times higher for per-
sons with IBS to experience extreme pain or discomfort as
compared to persons without IBS(p= 0.002) . The prob-
ability of being moderately anxious or depressed and of
being extremely anxious or depressed is also higher for
persons suffering from IBS (2.39 times, p < 0.001 and 3.68
times, p = 0.037, respectively) (Table 2).
The mean EQ-5D index score was 0.739 for IBS and
0.854 for non-IBS. After adjustment for age, gender and
presence of significant illnesses in another family mem-
ber of the participant, the effect of IBS on the EQ-5D
still showed a significant difference [−0.11 (95% CI: -0.15
to −0.07), p < 0.001] (Table 3).
Discussion
This study found that persons with IBS symptoms that
meet the Rome III criteria have poorer quality of life. Ourcohort of community-based IBS sufferers had a mean EQ-
5D index score of 0.739 which is comparable to patients
who suffer from other serious and debilitating conditions
such as chronic ischaemic heart disease, which was shown
to have a mean index score of 0.738 in one study [14]. The
prevalence rate of IBS in Singapore has previously been
found to be rather high at 8.6% [15] with a clinic consult-
ation rate of 84% [16]. These high rates and the significant
negative impact contribute to a hefty disease burden and
increased healthcare costs to the community.
The literature on Western populations has shown that
among the five EQ-5D domains, pain/discomfort was the
most adversely affected while self-care was the least
affected in IBS sufferers [7]. In our study, we found that
pain/discomfort was most significantly affected in the IBS
sufferers as well. In addition to this, the mobility, activity
and anxiety/depression domains were also significantly
affected among the IBS sufferers. However, the self-care
domain was not significantly affected. To our knowledge,
no prior quality-of-life studies on IBS in Asia have used
the EQ-5D tool. However, a study in China which used SF
36 for IBS patients showed that the domain of “physical
function” was not affected [17]. It has also previously been
shown that the self-care domain in EQ-5D strongly corre-
lates with the “physical function” domain in SF 36 [7]. On
the other hand, the number of respondents who reported
any problems with self-care was very low [6 out of 449
patients (1.3%)]. Hence, it may not be sufficiently powered
to detect any difference between the two groups.
There is a “dose-related” association between anxiety
and depression with IBS. Respondents were more likely
to have IBS when they had a higher degree of reported
anxiety or depression. It is well-recognized that psycho-
logical disturbances are common in IBS [1] and may re-
sult in changes in perception of visceral sensations in
IBS patients [18]. However, secondary psychological pro-
blems can also develop as a result of a chronic debilitat-
ing condition such as IBS. While this cross-sectional
study cannot establish a causal relationship, the strong
association supports recommendation that psychological
disturbances should be actively explored and managed
in IBS patients [1].
There was a male preponderance in the IBS group
(53% vs 42%) but this was not significant on multivariate
analysis. One Indian study [19] has shown a significant
association of between males and IBS but most Asian
studies have shown parity between the genders [20]. Our
results reinforce the observations that the greatly
increased risk of IBS in women reported in the West is
not reflected in the Asian community [20]. The cause of
this difference is unknown and warrants further
investigation.
Asian studies show IBS is more prevalent in younger
and more educated individuals [20]. Our findings are in
Table 1 Factors associated with IBS status
IBS Odds ratio (univariate analysis) Odds ratio (multivariate analysis)
No Yes OR (95% CI) p-value OR (95% CI) p-value
Age [Median years (IQR)] 57 (50–62) 52 (44–59) 0.97 (0.95 - 0.99) <0.001 0.98 (0.96 - 0.995) .012
Gender Male 102 42% 105 53%
Female 143 58% 92 47% 0.62 (0.43 - 0.91) 0.015
Race Chinese 230 93% 179 91%
Indian 11 4% 11 6% 1.28 (0.54 - 3.03) 0.567
Malay 1 0% 2 1% 2.57 (0.23 - 28.57) 0.442
Others 5 2% 5 3% 1.28 (0.37 - 4.51) 0.695
Education Low level 135 56% 74 38%
High level 105 44% 121 62% 2.1 (1.43 - 3.09) <0.001 1.7 (1.114 - 2.581) .014
Work Unemployed 114 47% 68 35%
Employed 128 53% 128 65% 1.68 (1.14 - 2.47) 0.009
Illness in yourself No 53 24% 44 24%
Yes 170 76% 136 76% 0.96 (0.61 - 1.52) 0.874
Illness in Family No 81 50% 83 55%
Yes 82 50% 68 45% 0.81 (0.52 - 1.26) 0.350
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was also associated with employment although this dif-
ference was not significant on multivariate analysis. This
can be explained by the over-representation of retired
people in the unemployed group, who are significantly
older than the employed group (mean age was 64 years
in the unemployed group versus 49 years in the




Mobility No Problem 236 94% 1
Some Problems 15 6% 2
Self-care No Problem 248 99% 1
Some Problems 3 1%
Usual Activity No Problem 234 93% 1
Some Problems 17 7% 3
Pain/Discomfort No Pain or discomfort 143 57% 4
Some Pain or discomfort 104 41% 1
Extreme Pain or discomfort 4 2%
Anxiety/ Depression Not anxious or depressed 164 65% 9
Moderately anxious or depressed 82 33% 9
Extremely anxious or depressed 5 2%
a adjusted on Age and Education (remained significant on multivariate analysis).
b adjusted on Age and Education (remained significant on multivariate analysis).
c adjusted on Work and Education (remained significant on multivariate analysis).
d adjusted on Education (remained significant on multivariate analysis).
e adjusted on Age and Education (remained significant on multivariate analysis).employment and IBS has not been extensively studied
and it would be interesting to explore this association.
There are some limitations in this study. The first is
that the study population is from participants in a public
symposium focusing on gastrointestinal malignancy. It is
likely that many of them may have significant gastro-
intestinal symptoms and are better educated, both fac-





Yes OR (95% CI) p-value OR (95% CI) p-value
unt %
76 89%
2 11% 1.97 (0.99 - 3.9) 0.053 2.38 a (1.15 - 4.96) 0.020
95 98%
3 2% 1.27 (0.25 - 6.37) 0.770 1.58 b (0.22 - 11.52) 0.654
64 83%
4 17% 2.85 (1.54 - 5.28) 0.001 3.63 c (1.85 - 7.14) <0.001
0 20%
50 76% 5.16 (3.35 - 7.93) <0.001 4.92 d (3.15 - 7.68) <0.001
8 4% 7.15 (2.05 - 24.97) 0.002 7.93 d (2.2 - 28.57) 0.002
4 47%
6 48% 2.04 (1.38 - 3.01) <0.001 2.39 e (1.57 - 3.64) <0.001
8 4% 2.79 (0.89 - 8.78) 0.079 3.68 e (1.08 - 12.5) 0.037
Table 3 Linear regression - Impact of IBS status on
Quality of life (measured with the EQ-5D scale)
Coeff. 95% CI p-value
Non-adjusted non-IBS (reference)
IBS −0.114 −0.15 to −0.08 <0.001
Adjusted* non-IBS (reference)
IBS −0.109 −0.15 to −0.07 <0.001
*adjusted on age, gender and Illness in other family member (factors which
remained significant on multivariate analysis).
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of the country and data such as prevalence of IBS in this
group cannot be extrapolated to the nation. Nonetheless,
comparisons of HRQoL and the extent to which the in-
dividual domains are affected between IBS and non-IBS
respondents are valid. The second limitation is the use
of a self-reported questionnnaire for the diagnosis of
IBS. Without a formal evaluation by a physician to ex-
clude other diseases, the self-reported questionnaire may
have limited accuracy for the diagnosis of IBS. It would
be ideal if the conditions set forth by the regional con-
sensus guidelines [1] were adhered to.Conclusion
IBS is a prevalent condition with significant negative im-
pact on the quality of life. In our Chinese-predominant
study population, the HRQoL instrument, EQ-5D,
showed results and characteristics which were largely in
line with Western data but with minor differences which
were also observed with another HRQoL instrument in
China. The EQ-5D is a brief HRQoL tool which could
be considered for routine clinical application and for fu-
ture studies of IBS in Asia.
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